Skip to content

Youth Mayo Clinic Anxiety Coach Pilot Study

Expanding Access to Therapy for Childhood Anxiety Disorders Via Smart Phones - PILOT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02205177
Enrollment
10
Registered
2014-07-31
Start date
2016-01-15
Completion date
2017-03-31
Last updated
2019-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

Anxiety, Social Anxiety, Social Phobia, Separation Anxiety, Generalized Anxiety, GAD, Phobia, Panic, Agoraphobia, Obsessive Compulsive Disorder, OCD, Child, Adolescent, Smartphone, Teen, Youth

Brief summary

This research study aims to test the feasibility and effectiveness of using the Mayo Clinic Anxiety Coach smartphone app as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting.

Detailed description

This research study aims to test the feasibility and effectiveness of using the Mayo Clinic Anxiety Coach smartphone app as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting. Therapist will provide CBT to patients with infrequent face-to-face contact and then will examine the acceptability, ease of use and need for contact.

Interventions

Mayo Clinic Anxiety Coach is a smartphone application based on cognitive-behavioral treatment for anxiety disorders (i.e., exposure-based therapy) that can be used as 1) a stand-alone treatment requiring minimal provider contact, and 2) an augmentation of face-to-face treatment that increases clinician fidelity and patient adherence to evidence-based treatment. The design of Anxiety Coach is based on evidence and theory suggesting that information and communication technologies (ICTs) are well-suited for encouraging behavior change through 1) scheduled reminders to engage in therapeutic exercises, 2) point of performance support, 3) individually tailored information, 4) real-time symptom assessment, and 5) readily accessible asynchronous communication.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Stephen Whiteside
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Age 7 to 17 2. Primary diagnosis of: 1. social phobia, 2. separation anxiety disorder, 3. panic disorder with and without agoraphobia, 4. specific phobia, or 5. obsessive compulsive disorder 3. A parent or other primary care giver available to participate with the child in all assessment and treatment activities 4. Estimated average intelligence 5. English speaking

Exclusion criteria

1. History of and/or current diagnosis of: 1. psychosis, 2. autism, 3. bipolar disorder, 4. mental retardation, 5. oppositional defiant disorder, 6. PTSD, 7. selective mutism, or 8. major depressive disorder 2. Current suicidality or recent suicidal behavior 3. Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties 4. Starting or changing the dosage of a psychiatric medication in the last two months

Design outcomes

Primary

MeasureTime frameDescription
Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment CompletionWithin 5 working days of Treatment CompletionThe Pediatric Anxiety Rating Scale (PARS) is an interview-based tool used to assess for the presence and severity of anxiety symptoms in children and adolescents utilizing parental and youth input to guide clinician ratings. The PARS has 5 questions. Four of those questions has a scale ranging from none (1) to extreme (5). The other question has a rating of 1-5. The total score ranges from 0 - 25, with 25 being the worst.

Secondary

MeasureTime frameDescription
Number of Participants Who Completed the Subject Safety and Treatment Adherence InterviewWithin 5 working days of Treatment CompletionThe number of patients that completed the summary of the qualitative interview will be used to enhance Anxiety Coach

Countries

United States

Participant flow

Participants by arm

ArmCount
Face-to-Face w/ Anxiety Coach (FTF-AC)
Therapists will provide 6 to 12 50-minute, face-to-face therapy sessions using Anxiety Coach. The sessions occur weekly & within the office. Therapists will use Anxiety Coach at each session, encouraging patients to use the application to complete homework, & review progress in-session via the web-based portal. Mayo Clinic Anxiety Coach, a smartphone application based on cognitive-behavioral treatment for anxiety disorders can be used as a stand-alone treatment using minimal provider contact & an augmentation of face-to-face treatment that increases clinician fidelity & patient adherence to evidence-based treatment. Anxiety Coach's design is based on evidence & theory suggesting that information & communication technologies (ICTs) are well-suited for encouraging behavior change through scheduled reminders to engage in therapeutic exercises; point of performance support; individually tailored information; real-time symptom assessment & readily accessible asynchronous communication.
8
Minimal Contact w/ Anxiety Coach (MC-AC)
Therapist's will meet with the patient & parent for an initial 50-minute, face-to-face session to give a tutorial on using Anxiety Coach. The therapist will review the patient's progress via the web-based portal & communicate with patients electronically weekly for a total of 6 to 12 weeks of intervention. Mayo Clinic Anxiety Coach, a smartphone application based on cognitive-behavioral treatment for anxiety disorders can be used as a stand-alone treatment using minimal provider contact & an augmentation of face-to-face treatment that increases clinician fidelity & patient adherence to evidence-based treatment. Anxiety Coach's design is based on evidence & theory suggesting that information & communication technologies (ICTs) are well-suited for encouraging behavior change through scheduled reminders to engage in therapeutic exercises; point of performance support; individually tailored information; real-time symptom assessment & readily accessible asynchronous communication.
2
Total10

Baseline characteristics

CharacteristicFace-to-Face w/ Anxiety Coach (FTF-AC)Minimal Contact w/ Anxiety Coach (MC-AC)Total
Age, Categorical
<=18 years
8 Participants2 Participants10 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
8 Participants2 Participants10 Participants
Sex: Female, Male
Female
5 Participants2 Participants7 Participants
Sex: Female, Male
Male
3 Participants0 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 2
other
Total, other adverse events
0 / 80 / 2
serious
Total, serious adverse events
0 / 80 / 2

Outcome results

Primary

Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion

The Pediatric Anxiety Rating Scale (PARS) is an interview-based tool used to assess for the presence and severity of anxiety symptoms in children and adolescents utilizing parental and youth input to guide clinician ratings. The PARS has 5 questions. Four of those questions has a scale ranging from none (1) to extreme (5). The other question has a rating of 1-5. The total score ranges from 0 - 25, with 25 being the worst.

Time frame: Within 5 working days of Treatment Completion

ArmMeasureValue (MEAN)Dispersion
Face-to-Face w/ Anxiety Coach (FTF-AC)Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion11 score on a scaleStandard Deviation 3.1
Minimal Contact w/ Anxiety Coach (MC-AC)Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion-1 score on a scaleStandard Deviation 0.7
Secondary

Number of Participants Who Completed the Subject Safety and Treatment Adherence Interview

The number of patients that completed the summary of the qualitative interview will be used to enhance Anxiety Coach

Time frame: Within 5 working days of Treatment Completion

Population: No families from minimal contact responded to interview request. three of the families from the Face to Face condition did not respond to invitation to interview.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Face-to-Face w/ Anxiety Coach (FTF-AC)Number of Participants Who Completed the Subject Safety and Treatment Adherence Interview5 Participants
Minimal Contact w/ Anxiety Coach (MC-AC)Number of Participants Who Completed the Subject Safety and Treatment Adherence Interview0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026